⌘K

Login Start Free

Home/Filings/4/0001831283-22-000050

4//SEC Filing

GIANAKAKOS ANASTASIOS 4

Accession 0001831283-22-000050

CIK 0001831283other

View on SEC.gov Company Profile

Filed

Jun 26, 8:00 PM ET

Accepted

Jun 27, 4:17 PM ET

Size

5.3 KB

Accession

0001831283-22-000050

Insider Transaction Report

Form 4

Period: 2022-06-23

GIANAKAKOS ANASTASIOS

Director

Transactions

Award
Ordinary Shares
2022-06-23+36,300→ 36,300 total
Exercise: $2.52Exp: 2032-06-23→ Ordinary Shares (36,300 underlying)

Footnotes (1)

[F1]The shares underlying the option shall vest and become exercisable in full on June 23, 2023, the first anniversary of the grant date, subject to the Reporting Person providing continuous service to the Issuer through such date.

Documents

1 file

4
wf-form4_165636106038470.xmlPrimary
FORM 4

Issuer

LianBio

CIK 0001831283

Entity typeother

Related Parties

1

filerCIK 0001413822

Filing Metadata

Form type: 4
Filed: Jun 26, 8:00 PM ET
Accepted: Jun 27, 4:17 PM ET
Size: 5.3 KB

View on SEC.gov